These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12485520)
1. [The research the relationship between N-acetyltransferase 1 gene polymorphisms and genetic susceptibility to sporadic colorectal adenocarcinoma]. Zhang Y; Shi Z; Deng C; Zhu Y; Zhou Y Zhonghua Nei Ke Za Zhi; 2002 Nov; 41(11):746-9. PubMed ID: 12485520 [TBL] [Abstract][Full Text] [Related]
2. [The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma]. Zhu Y; Deng C; Zhang Y; Zhou X; He X Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):538-40. PubMed ID: 12421502 [TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
4. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594 [TBL] [Abstract][Full Text] [Related]
5. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581 [TBL] [Abstract][Full Text] [Related]
6. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961 [TBL] [Abstract][Full Text] [Related]
7. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440 [TBL] [Abstract][Full Text] [Related]
10. N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population. Zhangwei X; Jianming X; Qiao M; Xinhua X Clin Chim Acta; 2006 Sep; 371(1-2):85-91. PubMed ID: 16600204 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461 [TBL] [Abstract][Full Text] [Related]
12. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267 [TBL] [Abstract][Full Text] [Related]
13. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cascorbi I; Roots I; Brockmöller J Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340 [TBL] [Abstract][Full Text] [Related]
14. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes. Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877 [TBL] [Abstract][Full Text] [Related]
15. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe. McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719 [TBL] [Abstract][Full Text] [Related]
16. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Probst-Hensch NM; Haile RW; Li DS; Sakamoto GT; Louie AD; Lin BK; Frankl HD; Lee ER; Lin HJ Carcinogenesis; 1996 Oct; 17(10):2125-9. PubMed ID: 8895478 [TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies. Wu K; Wang X; Xie Z; Liu Z; Lu Y J Int Med Res; 2013 Feb; 41(1):31-7. PubMed ID: 23569127 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility. Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer. Yeh CC; Sung FC; Tang R; Chang-Chieh CR; Hsieh LL Dis Colon Rectum; 2009 Jan; 52(1):104-11. PubMed ID: 19273964 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]